PortfoliosLab logoPortfoliosLab logo
XERS vs. FIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

XERS vs. FIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xeris Biopharma Holdings, Inc. (XERS) and Comfort Systems USA, Inc. (FIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XERS achieves a -24.97% return, which is significantly lower than FIX's 98.41% return.


XERS

1D
-1.83%
1M
-7.10%
YTD
-24.97%
6M
-12.48%
1Y
26.67%
3Y*
27.83%
5Y*
7.78%
10Y*

FIX

1D
-1.76%
1M
-2.18%
YTD
98.41%
6M
95.06%
1Y
273.24%
3Y*
129.39%
5Y*
85.41%
10Y*
50.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XERS vs. FIX - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
XERS
Xeris Biopharma Holdings, Inc.
-24.97%131.56%44.26%76.69%-54.61%-40.45%-30.21%-58.53%-15.92%
FIX
Comfort Systems USA, Inc.
98.41%120.86%106.89%79.62%16.98%88.98%6.73%15.07%-5.68%

Correlation

The correlation between XERS and FIX is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jun 22, 2018

0.22

The correlation between XERS and FIX shifts across timeframes, from 0.10 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

XERS:

$1.05B

FIX:

$65.22B

EPS

XERS:

$0.07

FIX:

$34.64

PE Ratio

XERS:

84.77

FIX:

53.41

PS Ratio

XERS:

3.23

FIX:

6.45

PB Ratio

XERS:

80.41

FIX:

23.17

Total Revenue (TTM)

XERS:

$314.85M

FIX:

$10.14B

Gross Profit (TTM)

XERS:

$187.04M

FIX:

$2.55B

EBITDA (TTM)

XERS:

$41.72M

FIX:

$1.70B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XERS vs. FIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XERS
XERS Risk / Return Rank: 5555
Overall Rank
XERS Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
XERS Sortino Ratio Rank: 5555
Sortino Ratio Rank
XERS Omega Ratio Rank: 5656
Omega Ratio Rank
XERS Calmar Ratio Rank: 5454
Calmar Ratio Rank
XERS Martin Ratio Rank: 5252
Martin Ratio Rank

FIX
FIX Risk / Return Rank: 9898
Overall Rank
FIX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
FIX Sortino Ratio Rank: 9898
Sortino Ratio Rank
FIX Omega Ratio Rank: 9797
Omega Ratio Rank
FIX Calmar Ratio Rank: 9999
Calmar Ratio Rank
FIX Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XERS vs. FIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xeris Biopharma Holdings, Inc. (XERS) and Comfort Systems USA, Inc. (FIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XERSFIXDifference
Sharpe ratioReturn per unit of total volatility

-4.70

Sortino ratioReturn per unit of downside risk

-3.94

Omega ratioGain probability vs. loss probability

1.14

1.67

-0.53

Calmar ratioReturn relative to maximum drawdown

0.58

19.99

-19.41

Martin ratioReturn relative to average drawdown

1.05

62.95

-61.90

XERS vs. FIX - Sharpe Ratio Comparison

The current XERS Sharpe Ratio is 0.48, which is lower than the FIX Sharpe Ratio of 5.18. The chart below compares the historical Sharpe Ratios of XERS and FIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XERSFIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.48

5.18

-4.70

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.11

1.93

-1.82

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.21

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.18

0.40

-0.58

Drawdowns

XERS vs. FIX - Drawdown Comparison

The maximum XERS drawdown since its inception was -96.22%, roughly equal to the maximum FIX drawdown of -93.36%. Use the drawdown chart below to compare losses from any high point for XERS and FIX.


Loading charts...

Drawdown Indicators


XERSFIXDifference

Max Drawdown

Largest peak-to-trough decline

-96.22%

-93.36%

-2.86%

Max Drawdown (1Y)

Largest decline over 1 year

-46.57%

-13.77%

-32.80%

Max Drawdown (3Y)

Largest decline over 3 years

-50.67%

-46.05%

-4.62%

Max Drawdown (5Y)

Largest decline over 5 years

-78.59%

-46.05%

-32.54%

Max Drawdown (10Y)

Largest decline over 10 years

-49.68%

Current Drawdown

Current decline from peak

-78.37%

-9.38%

-68.99%

Average Drawdown

Average peak-to-trough decline

-79.05%

-38.09%

-40.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.59%

4.36%

+21.23%

Volatility

XERS vs. FIX - Volatility Comparison

Xeris Biopharma Holdings, Inc. (XERS) and Comfort Systems USA, Inc. (FIX) have volatilities of 12.65% and 12.90%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XERSFIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.65%

12.90%

-0.25%

Volatility (6M)

Calculated over the trailing 6-month period

34.32%

37.41%

-3.09%

Volatility (1Y)

Calculated over the trailing 1-year period

56.21%

53.25%

+2.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.54%

44.43%

+24.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

79.18%

42.33%

+36.85%

Dividends

XERS vs. FIX - Dividend Comparison

XERS has not paid dividends to shareholders, while FIX's dividend yield for the trailing twelve months is around 0.14%.


PositionTTM20252024202320222021202020192018201720162015
FIX
Comfort Systems USA, Inc.
0.14%0.21%0.28%0.41%0.49%0.49%0.81%0.79%0.76%0.68%0.83%0.88%
XERS
Xeris Biopharma Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

XERS vs. FIX - Financials Comparison

This section allows you to compare key financial metrics between Xeris Biopharma Holdings, Inc. and Comfort Systems USA, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B20222023202420252026
83.13M
2.87B
(XERS) Total Revenue
(FIX) Total Revenue
Values in USD except per share items

XERS vs. FIX - Profitability Comparison

The chart below illustrates the profitability comparison between Xeris Biopharma Holdings, Inc. and Comfort Systems USA, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
26.3%
Portfolio components
XERS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Xeris Biopharma Holdings, Inc. reported a gross profit of 0.00 and revenue of 83.13M. Therefore, the gross margin over that period was 0.0%.

FIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Comfort Systems USA, Inc. reported a gross profit of 754.41M and revenue of 2.87B. Therefore, the gross margin over that period was 26.3%.

XERS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Xeris Biopharma Holdings, Inc. reported an operating income of 7.92M and revenue of 83.13M, resulting in an operating margin of 9.5%.

FIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Comfort Systems USA, Inc. reported an operating income of 485.72M and revenue of 2.87B, resulting in an operating margin of 17.0%.

XERS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Xeris Biopharma Holdings, Inc. reported a net income of 2.23M and revenue of 83.13M, resulting in a net margin of 2.7%.

FIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Comfort Systems USA, Inc. reported a net income of 370.38M and revenue of 2.87B, resulting in a net margin of 12.9%.


Frequently Asked Questions


XERS and FIX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FIX has higher volatility (12.90%) compared to XERS (12.65%). In terms of maximum drawdown, XERS dropped -96.22% vs FIX's -93.36%.

FIX currently has the higher Sharpe Ratio (5.18 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XERS and FIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer